DUTKO WORLDWIDE, LLC for BIOGENIDEC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Monitoring implementation and legislation affecting the IP issues in health care: legislation to create a regulatory pathway for biosimiliars, Pathway for Biosimilars Act (H.R. 1548) and Health Care Reform Legislation (to date no specific bills have been introduced).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| DARREN WILLCOX | — |
Health Issues HCR
Monitoring implementation and legislation affecting the Medicare program, legislation to create a regulatory pathway for biosimiliars, Pathway for Biosimilars Act (H.R. 1548) and Health Care Reform Legislation (to date no specific bills have been introduced).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Monitoring implementation and legislation affecting the Medicare program, legislation to create a regulatory pathway for biosimiliars, Pathway for Biosimilars Act (H.R. 1548) and Health Care Reform Legislation (to date no specific bills have been introduced).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS | — |
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.